Tumor Necrosis Factor-Alpha as Differential Diagnostic Marker for Patients with Fever of Unknown Origin

1. Abbas AK, Lichtman AH, Pillai S. Cellular and molecular immunology. 7th. ed. Philadelphia: Elsevier, Saunders; 2012. x, 545 p. p.Search in Google Scholar

2. Janeway C. Immunobiology : the immune system in health and disease. 6th ed. New York: Garland Science; 2005. xxiii, 823 p. p.Search in Google Scholar

3. Murphy K, Travers P, Walport M, Janeway C. Janeway’s immunobiology. 8th ed. New York: Garland Science; 2012. xix, 868 p. p.Search in Google Scholar

4. Hasday JD, Thompson C, Singh IS. Fever, immunity, and molecular adaptations. Comprehensive Physiology. 2014;4(1):109-48.10.1002/cphy.c13001924692136Search in Google Scholar

5. Sugimoto Y, Narumiya S. Prostaglandin E receptors. The Journal of biological chemistry. 2007;282(16):11613-7.10.1074/jbc.R60003820017329241Search in Google Scholar

6. Thelen M, Stein JV. How chemokines invite leukocytes to dance. Nature immunology. 2008;9(9):953-9.10.1038/ni.f.2071871143218711432Open DOISearch in Google Scholar

7. Yoshimura A, Naka T, Kubo M. SOCS proteins, cytokine signalling and immune regulation. Nature reviews Immunology. 2007;7(6):454-65.10.1038/nri209317525754Open DOISearch in Google Scholar

8. Malek TR. The biology of interleukin-2. Annual review of immunology. 2008;26:453-79.10.1146/annurev.immunol.26.021607.09035718062768Search in Google Scholar

9. Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annual review of immunology. 2007;25:821-52.10.1146/annurev.immunol.25.022106.14155717201677Search in Google Scholar

10. Feng P, Jyotaki M, Kim A, Chai J, Simon N, Zhou M, et al. Regulation of bitter taste responses by tumor necrosis factor. Brain Behav Immun. 2015;49:32-42.10.1016/j.bbi.2015.04.001456743225911043Search in Google Scholar

11. Starkie R, Ostrowski SR, Jauffred S, Febbraio M, Pedersen BK. Exercise and IL-6 infusion inhibit endotoxin- induced TNF-alpha production in humans. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2003;17(8):884-6.10.1096/fj.02-0670fje12626436Search in Google Scholar

12. Aggarwal BB, Gupta SC, Kim JH. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey. Blood. 2012;119(3):651-65.10.1182/blood-2011-04-325225326519622053109Search in Google Scholar

13. Balkwill F. Tumour necrosis factor and cancer. Nature reviews Cancer. 2009;9(5):361-71.10.1038/nrc262819343034Open DOISearch in Google Scholar

14. Petersdorf RG, Beeson PB. Fever of unexplained origin: report on 100 cases. Medicine. 1961;40:1-30.10.1097/00005792-196102000-00001Open DOISearch in Google Scholar

15. Durack DT, Street AC. Fever of unknown origin-reexamined and redefined. Current clinical topics in infectious diseases. 1991;11:35-51.Search in Google Scholar

16. Cunha BA. Fever of unknown origin: focused diagnostic approach based on clinical clues from the history, physical examination, and laboratory tests. Infectious disease clinics of North America. 2007;21(4):1137-87, xi.10.1016/j.idc.2007.09.004Search in Google Scholar

17. Ergonul O, Willke A, Azap A, Tekeli E. Revised definition of ‘fever of unknown origin’: limitations and opportunities. The Journal of infection. 2005;50(1):1-5.10.1016/j.jinf.2004.06.007Search in Google Scholar

18. Finch RG DG, Čivljak R. Fever of unknown origin. In: Begovac J BD, Lisić M, editor. Infectology. Zagreb: Profil International; 2006. p. 123−7.Search in Google Scholar

19. Dinarello CA, Gatti S, Bartfai T. Fever: links with an ancient receptor. Current biology : CB. 1999;9(4):R147-50.10.1016/S0960-9822(99)80085-2Open DOISearch in Google Scholar

20. Conti B, Tabarean I, Andrei C, Bartfai T. Cytokines and fever. Frontiers in bioscience: a journal and virtual library. 2004;9:1433-49.10.2741/134114977558Search in Google Scholar

21. Chan-Tack KM CB, Bartlett J, Sanders CV, Talavera F. Fever unknown origin: Medscape from WebMD; 2011 (cited 2012 8 July 2012).Search in Google Scholar

22. M. P. Febrilno stanje nepoznatnog uzroka. In: bolesti Kzi, editor. Infektivne bolesti. Beograd: Medicinski fakultet Univerziteta u Beogradu; 2004. p. 387-91.Search in Google Scholar

23. Bosnic D, Baresic M, Padjen I, Balenovic A, Zarkovic K, Anic B. Fever of unknown origin: large vessel vasculitis diagnosed by PET/CT. Rheumatology international. 2013;33(9):2417-21.10.1007/s00296-012-2425-122453531Open DOISearch in Google Scholar

24. Basu S, Ranade R. 18-Fluoro-deoxyglucose-PET/Computed Tomography in Infection and Aseptic Inflammatory Disorders: Value to Patient Management. PET clinics. 2015;10(3):431-9.10.1016/j.cpet.2015.03.00626099677Search in Google Scholar

25. Popovska-Jovičić B, Čanović P, Gajović O, Raković I. and Mijailović Ž. Fever of unknown origin: Most frequent causes in adults patients. Vojnosanit Pregl 2016; 73 (1): 21-25.10.2298/VSP140820128P26964380Search in Google Scholar

26. Aggarwal BB, Gupta SC, Sung B. Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers. British journal of pharmacology. 2013;169(8):1672-92.10.1111/bph.12131375382923425071Search in Google Scholar

27. Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell death and differentiation. 2003;10(1):45-65.10.1038/sj.cdd.440118912655295Search in Google Scholar

28. Kant S, Swat W, Zhang S, Zhang ZY, Neel BG, Flavell RA, et al. TNF-stimulated MAP kinase activation mediated by a Rho family GTPase signaling pathway. Genes & development. 2011;25(19):2069-78.10.1101/gad.17224711319720521979919Search in Google Scholar

29. Raaschou P, Simard JF, Asker Hagelberg C, Askling J. Rheumatoid arthritis, anti-tumour necrosis factor treatment, and risk of squamous cell and basal cell skin cancer: cohort study based on nationwide prospectively recorded data from Sweden. Bmj. 2016;352:i262.10.1136/bmj.i262473098926823527Search in Google Scholar

30. Sandri MT, Passerini R, Leon ME, Peccatori EA, Zorzino L, Salvatici M, Riggio D, Cassatella C, Cinieri S, and Martinelli G. Procalcitonin as a useful marker of infection in hemato-oncological patients with fever. Anticancer research 2008; 28: 3061-3066.Search in Google Scholar

31. Pukac L, Kanakaraj P, Humphreys R, Alderson R, Bloom M, Sung C, Riccobene T, Johnson R, et al. “HGS-ETR1, a fully human TRAIL-receptor 1 monoclonal antibody, induces cell death in multiple tumour types in vitro and in vivo”. British Journal of Cancer, 2005; 92 (8): 1430–41. doi:10.1038/sj.bjc.660248710.1038/sj.bjc.6602487236199415846298Search in Google Scholar

32. Barrie JR, English JC, Muller N: Castleman’s disease of the lung: radiographic, high-resolution CT, and pathologic findings. AJR Am J Roentgenol 1996; 166:1055-105610.2214/ajr.166.5.86152418615241Search in Google Scholar